Indian Growth Expected To Top A Tenth
ICRA Forecasts Indian Pharma Revenue Growth Of 11%-13%
Executive Summary
Indian credit rating agency ICRA has forecast that the country’s pharmaceutical industry will remain on a steady 11%-13% growth path this fiscal year, underpinned by healthy domestic demand, new launches and market share gains.